Exyte Belgium

{
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Luik",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2026-06-10",
    "filing_date": "2026-06-02",
    "act_kind_objet": "NEERLEGGNG TER GRIFFIE VAN DE Ondernemingsrechterbank Gent afdeling Dendermonde"
  },
  "decision": {
    "body": "enig_aandeelhouder_schriftelijk",
    "date": "2026-05-11",
    "unanimous": true
  },
  "agm_change": null,
  "detected_kind": "officer_designation",
  "other_address": null,
  "mandate_renewal": null,
  "subject_company": {
    "kbo": "1022.241.824",
    "name_full": "Exyte Belgium",
    "legal_form": "BV"
  },
  "accounts_deposit": null,
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "CMS Belgium",
    "person_name": "Charles HAVERBEKE",
    "org_rep_person_name": null
  },
  "co_filed_documents": [],
  "fiscal_year_change": null,
  "liquidation_closure": null,
  "officer_designation": {
    "role": "bestuurder",
    "organ": "raad_van_bestuur",
    "person_name": "Bertrand BIGEARD"
  },
  "special_procuration": {
    "grantee_kbo": null,
    "grantee_name": "St\u00E9phane Collin en/of de heer Nicolas Plumier en/of de heer Charles Haverbeke en/of elke andere advocaat van het advocatenkantoor CMS Belgium",
    "grantor_name": "Exyte Belgium",
    "scope_summary": "Verlenen van een bijzondere volmacht om alle formaliteiten te vervullen die nodig zijn voor de uitvoering van de besluiten en de publicatie ervan in het Belgisch Staatsblad, inclusief het ondertekenen van verklaringen en documenten.",
    "monetary_cap_eur": null,
    "scope_categories": [
      "publication"
    ],
    "termination_clause": null,
    "substitution_allowed": true
  },
  "is_volet_a_only_stub": false,
  "vakbekwaamheid_change": null,
  "should_reroute_to_category": null,
  "single_shareholder_declaration": {
    "art_csa": null,
    "effective_date": "2026-05-11",
    "shareholder_kbo": null,
    "shareholder_name": null
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 655239,
      "currency": "EUR",
      "after_eur": null,
      "delta_eur": 0,
      "before_eur": null,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2025-09-08",
      "evidence_quote": "besluit de algemene vergadering aan de enige aandeelhouder van de Overgenomen Vennootschap 655.239 nieuwe aandelen toe te kennen",
      "contribution_type": "in_kind"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "1022.241.824",
    "name_full": "EXYTE BELGIUM",
    "legal_form": "BV"
  }
}

{
  "stage": "proposal",
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2025-08-04",
    "filing_date": "2025-07-25",
    "act_kind_objet": "Neerlegging van het gezamenlijk voorstel van fusie door overneming van de vennootschap Pharmaplan door de vennootschap Exyte Belgium"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2025-07-18",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": {
    "summary": "Aan de aandeelhouders zal worden voorgesteld om te verzaken aan het opstellen van de verslagen zoals bedoeld in de artikelen 12:25 en 12:26 van het WVV, zodat er geen bezoldiging zal worden betaald aan de commissarissen in dit verband.",
    "articles": [
      "12:25",
      "12:26"
    ]
  },
  "restructuring": {
    "parties": [
      {
        "kbo": "1022.241.824",
        "name": "Exyte Belgium",
        "role": "acquiring",
        "address": "Schaarbeekstraat 23A, 9120 Beveren-Kruibeke-Zwijndrecht, Belgi\u00EB",
        "is_foreign": false,
        "legal_form": "Besloten vennootschap",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": "0845.886.619",
        "name": "Pharmaplan",
        "role": "absorbed",
        "address": "Boulevard de France 9, bus A, 1420 Braine-l\u0027Alleud, Belgi\u00EB",
        "is_foreign": false,
        "legal_form": "naamloze vennootschap",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": 7.445897727272727,
    "legal_articles": [
      "12:24",
      "12:25",
      "12:26"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": "2025-04-30",
    "exchange_ratio_text": "1 aandeel van de Overgenomen Vennootschap voor 7,445897727272727 aandelen die door de Overnemende Vennootschap moeten worden uitgegeven",
    "new_shares_issued_n": 655239,
    "real_estate_included": true,
    "patrimony_description": "Het algeheel vermogen, zowel de activa als de passiva, van de Overgenomen Vennootschap zal overgaan op de Overnemende Vennootschap.",
    "equity_transferred_eur": 440000.0,
    "accounting_effective_date": "2025-04-11"
  },
  "subject_company": {
    "kbo": "1022.241.824",
    "name_full": "Exyte Belgium",
    "legal_form": "Besloten vennootschap"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "CMS DeBacker",
    "person_name": null,
    "org_rep_person_name": "Ornella Le Brun"
  },
  "summary_narrative": "De vennootschap Exyte Belgium (Overnemende Vennootschap) voert een fusie door overneming uit met de vennootschap Pharmaplan (Overgenomen Vennootschap). Het volledige vermogen van Pharmaplan zal na haar ontbinding zonder vereffening overgaan op Exyte Belgium. De fusie zal juridisch in werking treden op 8 september 2025 en boekhoudkundig en fiscaal met terugwerkende kracht vanaf 11 april 2025.",
  "co_filed_documents": [],
  "detected_real_type": "fusion_proposal",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Katrien Six",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-04-11",
      "evidence_quote": "De raad van bestuur benoemt de mevrouw Katrien Six, woonplaats kiezend op de zetel van de Vennootschap, als dagelijks bestuurder van de Vennootschap, overeenkomstig artikel 15.1 van de statuten van de Vennootschap met ingang van 11 april 2025."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "1022.241.824",
    "name_full": "EXYTE BELGIUM",
    "legal_form": "BV"
  }
}

{
  "kind": "oprichting",
  "seat": "9120 Beveren-Kruibeke-Zwijndrecht, Schaarbeekstraat 23A",
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "founders": [
    {
      "org": {
        "kbo": "1019.757.238",
        "name": "Exyte Europe Holding"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": "naam",
      "partner_role": null,
      "holder_org_kbo": "1019.757.238",
      "holder_org_name": "Exyte Europe Holding",
      "contribution_type": "cash",
      "amount_paid_in_eur": 1000,
      "holder_person_name": null,
      "is_subscriber_only": true,
      "n_shares_subscribed": 1000,
      "amount_subscribed_eur": 1000,
      "is_anonymous_silent_partner": false
    }
  ],
  "capital_eur": 1000,
  "subject_company": {
    "kbo": "1022.241.824",
    "name_full": "Exyte Belgium",
    "legal_form": "BV"
  },
  "initial_directors": [],
  "incorporation_date": "2025-04-10",
  "post_incorporation_mandates": []
}